Health Dictionary Find a Doctor

Polycystic ovary syndrome future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

Overview

Overview

Future or Investigational Therapies

Future or Investigational Therapies

D-chiro-inositol (DCI) offers a well-tolerated and effective alternative treatment for PCOS. It has been evaluated in two peer-reviewed, double-blind studies and found to help both lean and obese women with PCOS; diminishing many of the primary clinical presentations of PCOS.[1] [2] It has no known side-effects and is a naturally occurring human metabolite known to be involved in insulin metabolism.[3] Contrary to common — but false — claims, DCI is not a drug but rather a nutrient (as defined by the DSHEA) and is commercially available as a nutritional supplement in the USA.

Ian Stoakes, a UK-based scientist has recently claimed some success in treating PCOS through tailored diets, believing that there is a strong link between PCOS, diabetes (and associated diseases) and inflammation caused by the failure of the blood to absorb specific foods. Blood samples are tested to see how they react to different food types to provide the patient with a list of foods she can eat and foods to avoid. Weight loss, alleviation of symptoms and successful pregnancies are claimed for this approach. It remains a totally unproven approach with no research papers listed in PubMed by Stoakes concerning PCOS.

References

References

  1. Nestler J E, Jakubowicz D J, Reamer P, Gunn R D, Allan G (1999). “Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome”. N Engl J Med. 340 (17): 1314&ndash, 1320. PMID 10219066.
  2. Iuorno M J, Jakubowicz D J, Baillargeon J P, Dillon P, Gunn R D, Allan G, Nestler J E (2002). “Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome”. Endocr Pract. 8 (6): 417&ndash, 423. PMID 15251831.
  3. Larner J (2002). “D-chiro-inositol–its functional role in insulin action and its deficit in insulin resistance”. Int J Exp Diabetes Res. 3 (1): 47&ndash, 60. PMID 11900279.


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH